✦ LIBER ✦

Potential Role of Genetic Markers in the Management of Kidney Cancer

✍ Scribed by Kerstin Junker; Vincenzo Ficarra; Eugene D. Kwon; Bradley C. Leibovich; R. Houston Thompson; Egbert Oosterwijk

Book ID: 118035202
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 243 KB
Volume: 63
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2012.09.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Role of Genetic Markers in the Manag

The Role of Genetic Markers in the Management of Prostate Cancer

✍ Atish D. Choudhury; Rosalind Eeles; Stephen J. Freedland; William B. Isaacs; Mar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 414 KB

Molecular markers in prostate cancer. Pa

Molecular markers in prostate cancer. Part II: potential roles in management

✍ Agrawal, Sachin; Patil, Krishnaji P.; Dunsmuir, William D. 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 344 KB

The role of tumor markers in breast canc

The role of tumor markers in breast cancer management

✍ Corrine Lenahan; Lilit Garibyan; Susan Pories 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 97 KB

The Role of Genetic Markers in the Evalu

The Role of Genetic Markers in the Evaluation and Management of Thyroid Nodules

✍ Parangi, Sareh; Suh, Hyunsuk 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 843 KB

The potential impact of adding genetic m

The potential impact of adding genetic markers to clinical parameters in managing high-risk prostate cancer patients

✍ Alvarez-Cubero, Maria; Martinez-Gonzalez, Luis; Vazquez-Alonso, Fernando; Saiz, 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 204 KB

Potential roles of genetic biomarkers in

Potential roles of genetic biomarkers in colorectal cancer chemoprevention

✍ Sapna Syngal; Gerard Clarke; Prathap Bandipalliam 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Colorectal cancer is a significant cause of morbidity and mortality in industrialized societies and the second most frequent cause of cancer death in the United States. Surrogate endpoint biomarkers are gaining wide acceptance in early diagnosis and short-term cancer chemoprevention trials in place